Rheonix®, Inc. has created a powerful microfluidic platform for the evolving molecular diagnostics industry that miniaturizes and automates all the functions of a molecular biology lab on a disposable chip the size of the palm of your hand.

The Rheonix CARD® (Chemistry And Reagent Device) system incorporates disposable microfluidic chip technology and a scalable automated platform to analyze single or multiple clinical raw samples, providing multiplexed endpoint analysis for a wide breadth of diagnostic applications.

Successful pilot programs have applied the Rheonix CARD system to a broad range of functional assays including immunoassay, pathogen identification, gene sequence detection, cell based assays and other molecular diagnostic applications.

Help Rheonix win a speaking slot at the 2012 BIO International Convention! Visit the Buzz of Bio website and vote for Rheonix under the "Technologies of Tomorrow" category.